Cargando…
A Novel Inhibitor of Mammalian Triosephosphate Isomerase Found by an In Silico Approach
Triosephosphate isomerase (TIM) is an essential, highly conserved component of glycolysis. Tumors are often dependent on glycolysis for energy and metabolite production (the Warburg effect). Glycolysis inhibitors thus show promise as cancer treatments. TIM inhibition, unlike inhibition of other glyc...
Autores principales: | Marsh, Lorraine, Shah, Kaushal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4207401/ https://www.ncbi.nlm.nih.gov/pubmed/25383217 http://dx.doi.org/10.1155/2014/469125 |
Ejemplares similares
-
Novel and Selective Rhipicephalus microplus Triosephosphate Isomerase Inhibitors with Acaricidal Activity
por: Saramago, Luiz, et al.
Publicado: (2018) -
Novel and selective inactivators of Triosephosphate isomerase with anti-trematode activity
por: Ferraro, Florencia, et al.
Publicado: (2020) -
Structure of triosephosphate isomerase from Cryptosporidium parvum
por: Nguyen, Trang N., et al.
Publicado: (2011) -
Identification of fibrillogenic regions in human triosephosphate isomerase
por: Carcamo-Noriega, Edson N., et al.
Publicado: (2016) -
Inhibition of triosephosphate isomerase by phosphoenolpyruvate in the feedback-regulation of glycolysis
por: Grüning, Nana-Maria, et al.
Publicado: (2014)